APA (7th ed.) Citation

JM, G., KE, H., TP, S., L, F., CD, Y., MV, E., . . . CL, A. (2017). Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance. Science translational medicine, 9(402), . https://doi.org/10.1126/scitranslmed.aai7993

Chicago Style (17th ed.) Citation

JM, Giltnane, et al. "Genomic Profiling of ER+ Breast Cancers After Short-term Estrogen Suppression Reveals Alterations Associated with Endocrine Resistance." Science Translational Medicine 9, no. 402 (2017). https://doi.org/10.1126/scitranslmed.aai7993.

MLA (9th ed.) Citation

JM, Giltnane, et al. "Genomic Profiling of ER+ Breast Cancers After Short-term Estrogen Suppression Reveals Alterations Associated with Endocrine Resistance." Science Translational Medicine, vol. 9, no. 402, 2017, https://doi.org/10.1126/scitranslmed.aai7993.